NCT05425979View on ClinicalTrials.gov

Mepivacaine Versus Bupivacaine Onset Time in Ultrasound-guided Ankle Blocks

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 11, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

March 30, 2027

Conditions
Ankle BlockFoot Surgery
Interventions
DRUG

Mepivacaine

Up to two 30 ml vials of mepivacaine 1.5% via ultrasound-guided nerve blockade of the tibial and deep peroneal nerves

DRUG

Bupivacaine

Up to two 30 ml vials of bupivacaine 0.5% via ultrasound-guided nerve blockade of the tibial and deep peroneal nerves

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05425979 - Mepivacaine Versus Bupivacaine Onset Time in Ultrasound-guided Ankle Blocks | Biotech Hunter | Biotech Hunter